(Q41113381)

26 September 2017

1 reference

title

Emerging fungal infections in cancer patients (English)

1 reference

26 September 2017

Krcmery V Jr

1

1 reference

26 September 2017

publication date

1 June 1996

1 reference

Journal of Hospital Infection

26 September 2017

published in

1 reference

26 September 2017

volume

33

1 reference

26 September 2017

issue

2

1 reference

26 September 2017

page(s)

109-117

1 reference

Systemic candidal infections associated with use of peripheral venous catheters in neonates: a 9-year experience

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

The clinical presentation and diagnosis of invasive fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Invasive infections due to Candida krusei: report of ten cases of fungemia that include three cases of endophthalmitis

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Opportunistic and pathogenic fungi

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Saprophytic molds as agents of cutaneous and subcutaneous infection in the immunocompromised host

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Fluconazole-resistant Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Prophylactic fluconazole and Candida krusei infections

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Invasive infection due to Candida krusei in immunocompromised patients not treated with fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Resistance of Candida species to fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Incidence of polyene-resistant yeasts recovered from clinical specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Development of Resistance to Amphotericin B in Candida lusitaniae Infecting a Human

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Fatal disseminated candidiasis due to amphotericin-B-resistant Candida guilliermondii

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Mycoses caused by Candida lusitaniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Amphotericin B-resistant yeast infection in severely immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Traumatic joint infection due to Geotrichum candidum

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Importance of Candida species other than C. albicans as pathogens in oncology patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Candidemia in a pediatric population

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2896%2990095-X

7 January 2021

10.1016/S0195-6701(96)90095-X

Identifiers

DOI

1 reference

26 September 2017

1 reference